Shine Corporate vs Slater & Gordon

How do these two legal firms stack up?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Recently listed legal firm Shine Corporate (ASX: SHJ) has released 2013 results. Shine focuses on damage-based plaintiff litigation and operates nationally although, its major representation is in Queensland. The announcement revealed:

  • Revenue of $105.4 million
  • NPAT (net profit after tax) of $17.5 million
  • EPS (earnings per share) 12.3c – based on weighted average number of shares
  • Gearing ratio 3.2% (net debt)

With largely regional exposure, Shine has the advantage of being the local go-to place for clients to contact should they wish to pursue personal injury or other damages claims. Cases can be undertaken on a no-win, no-fee basis. With a low gearing ratio, Shine has the capacity to pursue more acquisitions in order to spread geographic reach.

Projections indicate a 9% increase in revenue and a 12% increase in profit over the course of 2014, with key assumptions including maintaining an 84.5% recoverability rate and the addition of 18 new fee earners (practices).

So how does Shine compare with the other listed legal firm Slater & Gordon (ASX: SGH)?

Using 2013 results, Shine is capitalised at 15.5 times earnings and Slater & Gordon at 16.4 times. On growth prospects Slater & Gordon appears far better positioned with scale expansion into the UK. Shine may find integrating numerous smaller practices challenging – by comparison Slater & Gordon already has a significant national footprint. Of the two, Slater & Gordon appeals as the better value.

Want even more stock ideas? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Peter Andersen owns shares in Slater & Gordon.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »